PDL BioPharma Announces 2016 Second Quarter Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
PDL BioPharma (PDLI) Declares $0.05 Quarterly Dividend; 6.1% Yield
May 4, 2016 6:52 PM EDTPDL BioPharma (NASDAQ: PDLI) declared a quarterly dividend of $0.05 per share, or $0.2 annualized.
The dividend will be payable on June 13, 2016, to stockholders of record on June 6, 2016, with an ex-dividend date of June 2, 2016.
The annual yield on the dividend is 6.1... More
PDL BioPharma (PDLI) Tops Q1 EPS by 2c
May 4, 2016 6:51 PM EDTPDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $103.4 million versus the consensus estimate of $142.05 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
... More